Earendil

Earendil is a biotechnology company specializing in the application of generative artificial intelligence to protein engineering and drug discovery. The company develops advanced machine learning models designed to navigate the complex landscape of biological sequences, enabling the design of novel proteins and biologics with specific functional characteristics. By integrating computational predictions with high-throughput laboratory validation, Earendil seeks to significantly reduce the time and cost associated with developing next-generation therapeutics. Their platform is particularly focused on addressing targets that have been difficult to reach using traditional discovery methods.